<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39311385</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2311-553X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Non-coding RNA</Title><ISOAbbreviation>Noncoding RNA</ISOAbbreviation></Journal><ArticleTitle>Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">48</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ncrna10050048</ELocationID><Abstract><AbstractText>Following the acute phase of SARS-CoV-2 infection, certain individuals experience persistent symptoms referred to as long COVID. This study analyzed the patients categorized into three distinct groups: (1) individuals presenting rheumatological symptoms associated with long COVID, (2) patients who have successfully recovered from COVID-19, and (3) donors who have never contracted COVID-19. A notable decline in the expression of miR-200c-3p, miR-766-3p, and miR-142-3p was identified among patients exhibiting rheumatological symptoms of long COVID. The highest concentration of miR-142-3p was found in healthy donors. One potential way to reduce miRNA concentrations is through antibody-mediated hydrolysis. Not only can antibodies possessing RNA-hydrolyzing activity recognize the miRNA substrate specifically, but they also catalyze its hydrolysis. The analysis of the catalytic activity of plasma antibodies revealed that antibodies from patients with long COVID demonstrated lower hydrolysis activity against five fluorescently labeled oligonucleotide sequences corresponding to the Flu-miR-146b-5p, Flu-miR-766-3p, Flu-miR-4742-3p, and Flu-miR-142-3p miRNAs and increased activity against the Flu-miR-378a-3p miRNA compared to other patient groups. The changes in miRNA concentrations and antibody-mediated hydrolysis of miRNAs are assumed to have a complex regulatory mechanism that is linked to gene pathways associated with the immune system. We demonstrate that all six miRNAs under analysis are associated with a large number of signaling pathways associated with immune response-associated pathways.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Timofeeva</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-1270-7164</Identifier><AffiliationInfo><Affiliation>SB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikitin</LastName><ForeName>Artem O</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0009-0004-2006-3022</Identifier><AffiliationInfo><Affiliation>SB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nevinsky</LastName><ForeName>Georgy A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-4988-8923</Identifier><AffiliationInfo><Affiliation>SB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22-15-00103</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant><Grant><GrantID>0245-2021-0009 (121031300041-4)</GrantID><Agency>Russian State-funded budget project of ICBFM SB RAS</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Noncoding RNA</MedlineTA><NlmUniqueID>101652294</NlmUniqueID><ISSNLinking>2311-553X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RNA hydrolysis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">catalytic antibodies</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">miR-142-3p</Keyword><Keyword MajorTopicYN="N">miR-200c-3p</Keyword><Keyword MajorTopicYN="N">miR-766-3p</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword><Keyword MajorTopicYN="N">pathways</Keyword><Keyword MajorTopicYN="N">regulatory network</Keyword><Keyword MajorTopicYN="N">rheumatologically</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311385</ArticleId><ArticleId IdType="pmc">PMC11417918</ArticleId><ArticleId IdType="doi">10.3390/ncrna10050048</ArticleId><ArticleId IdType="pii">ncrna10050048</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kincaid R.P., Sullivan C.S. Virus-Encoded MicroRNAs: An Overview and a Look to the Future. PLoS Pathog. 2012;8:e1003018. doi: 10.1371/journal.ppat.1003018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003018</ArticleId><ArticleId IdType="pmc">PMC3534370</ArticleId><ArticleId IdType="pubmed">23308061</ArticleId></ArticleIdList></Reference><Reference><Citation>Intartaglia D., Giamundo G., Conte I. The Impact of MiRNAs in Health and Disease of Retinal Pigment Epithelium. Front. Cell Dev. Biol. 2021;8:589985. doi: 10.3389/fcell.2020.589985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.589985</ArticleId><ArticleId IdType="pmc">PMC7844312</ArticleId><ArticleId IdType="pubmed">33520981</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. 2018;9:402. doi: 10.3389/fendo.2018.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe3;o-Lima L.J., Morais A.H.F., Valentim R.A.M., Barreto E.J.S.S. MiRNAs as Biomarkers for Early Cancer Detection and Their Application in the Development of New Diagnostic Tools. Biomed. Eng. Online. 2021;20:21. doi: 10.1186/s12938-021-00857-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12938-021-00857-9</ArticleId><ArticleId IdType="pmc">PMC7885381</ArticleId><ArticleId IdType="pubmed">33593374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash S., Dash C., Pandhare J. Therapeutic Significance of MicroRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection. Non-Coding RNA. 2021;7:60. doi: 10.3390/ncrna7040060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna7040060</ArticleId><ArticleId IdType="pmc">PMC8544662</ArticleId><ArticleId IdType="pubmed">34698261</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmonte T., Perez-Pons M., Ben&#xed;tez I.D., Molinero M., Garc&#xed;a-Hidalgo M.C., Rodr&#xed;guez-Mu&#xf1;oz C., Gort-Paniello C., Moncus&#xed;-Moix A., Mad&#xe8; A., Devaux Y., et al. Addressing the Unsolved Challenges in MicroRNA-Based Biomarker Development: Suitable Endogenous Reference MicroRNAs for SARS-CoV-2 Infection Severity. Int. J. Biol. Macromol. 2024;269:131926. doi: 10.1016/j.ijbiomac.2024.131926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2024.131926</ArticleId><ArticleId IdType="pubmed">38688344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicik Z., Eyileten C., Nowak A., Keshwani D., Sim&#xf5;es S.N., Martins D.C., Klos K., Wlodarczyk W., Assinger A., Soldacki D., et al. Alteration of Circulating ACE2-Network Related MicroRNAs in Patients with COVID-19. Sci. Rep. 2024;14:13573. doi: 10.1038/s41598-024-58037-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-58037-3</ArticleId><ArticleId IdType="pmc">PMC11169442</ArticleId><ArticleId IdType="pubmed">38866792</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Giralt N., Du J., Marin-Corral J., B&#xf3;dalo-Torruella M., Blasco-Hernando F., Mu&#xf1;oz-Berm&#xfa;dez R., Clar&#xf3;s M., Nonell L., Perera-Bel J., Fernandez-Gonz&#xe1;lez M., et al. Circulating MicroRNA Profiling Is Altered in the Acute Respiratory Distress Syndrome Related to SARS-CoV-2 Infection. Sci. Rep. 2022;12:6929. doi: 10.1038/s41598-022-10738-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10738-3</ArticleId><ArticleId IdType="pmc">PMC9047579</ArticleId><ArticleId IdType="pubmed">35484171</ArticleId></ArticleIdList></Reference><Reference><Citation>Togami Y., Matsumoto H., Yoshimura J., Matsubara T., Ebihara T., Matsuura H., Mitsuyama Y., Kojima T., Ishikawa M., Sugihara F., et al. Significance of Interferon Signaling Based on MRNA-MicroRNA Integration and Plasma Protein Analyses in Critically Ill COVID-19 Patients. Mol. Ther.-Nucleic Acids. 2022;29:343&#x2013;353. doi: 10.1016/j.omtn.2022.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2022.07.005</ArticleId><ArticleId IdType="pmc">PMC9278015</ArticleId><ArticleId IdType="pubmed">35855895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Kyubwa E.M., Starbird M.A., Diaz de Leon J., Nguyen M., Rogers C.J., Menon N. Circulating MiRNA Profiles in COVID-19 Patients and Meta-Analysis: Implications for Disease Progression and Prognosis. Sci. Rep. 2023;13:21656. doi: 10.1038/s41598-023-48227-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48227-w</ArticleId><ArticleId IdType="pmc">PMC10709343</ArticleId><ArticleId IdType="pubmed">38065980</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza Nicoletti A., Berlofa Visacri M., Regina da Silva Correa da Ronda C., Tiemi Siguemoto J., Motta Neri C., Nogueira de Souza R., de Souza Ventura D., Eguti A., Ferreira de Souza Silva L., Wesley Perroud Junior M., et al. Increased Expression of MiR-320b in Blood Plasma of Patients in Response to SARS-CoV-2 Infection. Sci. Rep. 2024;14:13702. doi: 10.1038/s41598-024-64325-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-64325-9</ArticleId><ArticleId IdType="pmc">PMC11176351</ArticleId><ArticleId IdType="pubmed">38871789</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannella A., Riccetti S., Sinigaglia A., Piubelli C., Razzaboni E., Di Battista P., Agostini M., Dal Molin E., Manganelli R., Gobbi F., et al. Circulating MicroRNA Signatures Associated with Disease Severity and Outcome in COVID-19 Patients. Front. Immunol. 2022;13:968991. doi: 10.3389/fimmu.2022.968991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.968991</ArticleId><ArticleId IdType="pmc">PMC9403711</ArticleId><ArticleId IdType="pubmed">36032130</ArticleId></ArticleIdList></Reference><Reference><Citation>Duecker R.P., Adam E.H., Wirtz S., Gronau L., Khodamoradi Y., Eberhardt F.J., Donath H., Gutmann D., Vehreschild M.J.G.T., Zacharowski K., et al. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure. Int. J. Mol. Sci. 2021;22:10351. doi: 10.3390/ijms221910351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910351</ArticleId><ArticleId IdType="pmc">PMC8508658</ArticleId><ArticleId IdType="pubmed">34638691</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Hu X., Li L., Li J. Differential MicroRNA Expression in the Peripheral Blood from Human Patients with COVID-19. J. Clin. Lab. Anal. 2020;34:e23590. doi: 10.1002/jcla.23590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23590</ArticleId><ArticleId IdType="pmc">PMC7536972</ArticleId><ArticleId IdType="pubmed">32960473</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidert A.S., Hermann S., Brandes F., Kirchner B., Buschmann D., Billaud J.-N., Klein M., Lindemann A., Aue E., Schelling G., et al. Extracellular Vesicle Associated MiRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome. Front. Immunol. 2021;12:784028. doi: 10.3389/fimmu.2021.784028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.784028</ArticleId><ArticleId IdType="pmc">PMC8696174</ArticleId><ArticleId IdType="pubmed">34956213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q., Qi X., Ma J., Hu F., Wang X., Qin H., Li M., Huang S., Yang Y., Li Y., et al. Distinct MiRNAs Associated with Various Clinical Presentations of SARS-CoV-2 Infection. iScience. 2022;25:104309. doi: 10.1016/j.isci.2022.104309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104309</ArticleId><ArticleId IdType="pmc">PMC9044631</ArticleId><ArticleId IdType="pubmed">35502319</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Seeliger B., Derda A.A., Xiao K., Gietz A., Scherf K., Sonnenschein K., Pink I., Hoeper M.M., Welte T., et al. Circulating Cardiovascular microRNAs in Critically Ill COVID-19 Patients. Eur. J. Heart Fail. 2021;23:468&#x2013;475. doi: 10.1002/ejhf.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti A.d.S., Visacri M.B., da Ronda C.R.d.S.C., Vasconcelos P.E.d.N.S., Quintanilha J.C.F., de Souza R.N., Ventura D.d.S., Eguti A., Silva L.F.d.S., Perroud Junior M.W., et al. Differentially Expressed Plasmatic MicroRNAs in Brazilian Patients with Coronavirus Disease 2019 (COVID-19): Preliminary Results. Mol. Biol. Rep. 2022;49:6931&#x2013;6943. doi: 10.1007/s11033-022-07338-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07338-9</ArticleId><ArticleId IdType="pmc">PMC8929466</ArticleId><ArticleId IdType="pubmed">35301654</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafipour R., Mohammadi D., Estaki Z., Zarabadi K., Jalilvand M., Moghbelinejad S. Screening for Differentially Expressed MicroRNAs in BALF and Blood Samples of Infected COVID-19 ARDS Patients by Small RNA Deep Sequencing. J. Clin. Lab. Anal. 2022;36:e24672. doi: 10.1002/jcla.24672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24672</ArticleId><ArticleId IdType="pmc">PMC9539155</ArticleId><ArticleId IdType="pubmed">36166345</ArticleId></ArticleIdList></Reference><Reference><Citation>tenOever B.R. RNA Viruses and the Host MicroRNA Machinery. Nat. Rev. Microbiol. 2013;11:169&#x2013;180. doi: 10.1038/nrmicro2971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2971</ArticleId><ArticleId IdType="pubmed">23411862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad S.M.A.H., Wannigama D.L., Hirankarn N., McLellan A.D. The Impact of Non-Synonymous Mutations on MiRNA Binding Sites within the SARS-CoV-2 NSP3 and NSP4 Genes. Sci. Rep. 2023;13:16945. doi: 10.1038/s41598-023-44219-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44219-y</ArticleId><ArticleId IdType="pmc">PMC10560223</ArticleId><ArticleId IdType="pubmed">37805621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini Rad SM A., McLellan A.D. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host MicroRNA Targeting. Int. J. Mol. Sci. 2020;21:4807. doi: 10.3390/ijms21134807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21134807</ArticleId><ArticleId IdType="pmc">PMC7370282</ArticleId><ArticleId IdType="pubmed">32645951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanbo A., Furuyama W., Lin Z. RNA Virus-Encoded MiRNAs: Current Insights and Future Challenges. Front. Microbiol. 2021;12:679210. doi: 10.3389/fmicb.2021.679210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.679210</ArticleId><ArticleId IdType="pmc">PMC8266288</ArticleId><ArticleId IdType="pubmed">34248890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozomara A., Griffiths-Jones S. MiRBase: Integrating MicroRNA Annotation and Deep-Sequencing Data. Nucleic Acids Res. 2011;39:D152&#x2013;D157. doi: 10.1093/nar/gkq1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1027</ArticleId><ArticleId IdType="pmc">PMC3013655</ArticleId><ArticleId IdType="pubmed">21037258</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundhoff A., Sullivan C.S. Virus-Encoded MicroRNAs. Virology. 2011;411:325&#x2013;343. doi: 10.1016/j.virol.2011.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.01.002</ArticleId><ArticleId IdType="pmc">PMC3052296</ArticleId><ArticleId IdType="pubmed">21277611</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B.R. Five Questions about Viruses and MicroRNAs. PLoS Pathog. 2010;6:e1000787. doi: 10.1371/journal.ppat.1000787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000787</ArticleId><ArticleId IdType="pmc">PMC2829071</ArticleId><ArticleId IdType="pubmed">20195463</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco F., Lorefice E., Carissimi C., Laudadio I., Ciccosanti F., Di Rienzo M., Colavita F., Meschi S., Maggi F., Fimia G.M., et al. A MicroRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity. Non-Coding RNA. 2023;9:33. doi: 10.3390/ncrna9030033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna9030033</ArticleId><ArticleId IdType="pmc">PMC10301948</ArticleId><ArticleId IdType="pubmed">37368333</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales L., Oliveros J.C., Fernandez-Delgado R., TenOever B.R., Enjuanes L., Sola I. SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology. Cell Host Microbe. 2017;21:344&#x2013;355. doi: 10.1016/j.chom.2017.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.01.015</ArticleId><ArticleId IdType="pmc">PMC5662013</ArticleId><ArticleId IdType="pubmed">28216251</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Siu G.K.-H., Mok B.W.-Y., Sun J., Fung K.S.C., Lam J.Y.-W., Wong N.K., Gedefaw L., Luo S., Lee T.M.H., et al. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells. Cells. 2021;10:1762. doi: 10.3390/cells10071762.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071762</ArticleId><ArticleId IdType="pmc">PMC8307234</ArticleId><ArticleId IdType="pubmed">34359932</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos A.E., Martin-Nares E., Hern&#xe1;ndez-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells. 2021;10:3592. doi: 10.3390/cells10123592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123592</ArticleId><ArticleId IdType="pmc">PMC8700122</ArticleId><ArticleId IdType="pubmed">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R., Robertson E. Autoimmunity as the Comet Tail of COVID-19 Pandemic. World J. Clin. Cases. 2020;8:3621&#x2013;3644. doi: 10.12998/wjcc.v8.i17.3621.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i17.3621</ArticleId><ArticleId IdType="pmc">PMC7479552</ArticleId><ArticleId IdType="pubmed">32953841</ArticleId></ArticleIdList></Reference><Reference><Citation>Gollapudi S., Chimurkar V. Comprehensive Insights Into the Multi-Faceted Manifestations of COVID-19: A Narrative Review. Cureus. 2024;16:e63493. doi: 10.7759/cureus.63493.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.63493</ArticleId><ArticleId IdType="pmc">PMC11287236</ArticleId><ArticleId IdType="pubmed">39081420</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugino K., Ono H., Haraguchi S., Igarashi S., Hebisawa A., Tsuboi E. Post-coronavirus Disease 2019 Organizing Pneumonia Confirmed Pathologically by Video-assisted Thoracoscopic Surgery. Respirol. Case Rep. 2021;9:e0871. doi: 10.1002/rcr2.871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcr2.871</ArticleId><ArticleId IdType="pmc">PMC8552080</ArticleId><ArticleId IdType="pubmed">34745634</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdyrev E., Rusina P., Panova M., Novikov F., Grishagin I., Nebolsin V. Lung Fibrosis after COVID-19: Treatment Prospects. Pharmaceuticals. 2021;14:807. doi: 10.3390/ph14080807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14080807</ArticleId><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S., Abdelhak A., Foschi M., Tumani H., Otto M. Guillain&#x2013;Barr&#xe9; Syndrome Spectrum Associated with COVID-19: An up-to-Date Systematic Review of 73 Cases. J. Neurol. 2021;268:1133&#x2013;1170. doi: 10.1007/s00415-020-10124-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Koz&#x142;owski P., Leszczy&#x144;ska A., Ciepiela O. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review. Am. J. Med. Open. 2024;11:100068. doi: 10.1016/j.ajmo.2024.100068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajmo.2024.100068</ArticleId><ArticleId IdType="pmc">PMC11256271</ArticleId><ArticleId IdType="pubmed">39034937</ArticleId></ArticleIdList></Reference><Reference><Citation>Roghani S.A., Dastbaz M., Lotfi R., Shamsi A., Abdan Z., Rostampour R., Soleymani B., Zamanian M.H., Soufivand P., Pournazari M., et al. The Development of Anticyclic Citrullinated Peptide (Anti-CCP) Antibody Following Severe COVID-19. Immun. Inflamm. Dis. 2024;12:e1276. doi: 10.1002/iid3.1276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.1276</ArticleId><ArticleId IdType="pmc">PMC11112627</ArticleId><ArticleId IdType="pubmed">38780036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaffi J., Vanni E., Mancarella L., Brusi V., Lisi L., Pignatti F., Naldi S., Assirelli E., Neri S., Reta M., et al. Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review. Diagnostics. 2023;13:1850. doi: 10.3390/diagnostics13111850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13111850</ArticleId><ArticleId IdType="pmc">PMC10252492</ArticleId><ArticleId IdType="pubmed">37296705</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliorini F., Bell A., Vaishya R., Eschweiler J., Hildebrand F., Maffulli N. Reactive Arthritis Following COVID-19 Current Evidence, Diagnosis, and Management Strategies. J. Orthop. Surg. Res. 2023;18:205. doi: 10.1186/s13018-023-03651-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-023-03651-6</ArticleId><ArticleId IdType="pmc">PMC10017067</ArticleId><ArticleId IdType="pubmed">36922870</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Long S., Cort&#xe9;s-Altamirano J.L., Bandala C., Avenda&#xf1;o-Ortiz K., Bonilla-Jaime H., Bueno-Nava A., &#xc1;vila-Luna A., S&#xe1;nchez-Aparicio P., Clavijo-Cornejo D., Dotor-LLerena A.L., et al. Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review. Int. J. Mol. Sci. 2023;24:3574. doi: 10.3390/ijms24043574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043574</ArticleId><ArticleId IdType="pmc">PMC9963913</ArticleId><ArticleId IdType="pubmed">36834984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P., Jankauskas S.S., Manzi M.V., Gambardella J., Coppola A., Kansakar U., Izzo R., Fiorentino G., Lombardi A., Varzideh F., et al. Endothelial Extracellular Vesicles Enriched in MicroRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae. J. Pharmacol. Exp. Ther. 2024;389:34&#x2013;39. doi: 10.1124/jpet.122.001253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001253</ArticleId><ArticleId IdType="pmc">PMC10949163</ArticleId><ArticleId IdType="pubmed">38336381</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo C., Visco V., Gambardella J., Ferruzzi G.J., Rispoli A., Rusciano M.R., Toni A.L., Virtuoso N., Carrizzo A., Di Pietro P., et al. Cardiovascular Implications of MicroRNAs in Coronavirus Disease 2019. J. Pharmacol. Exp. Ther. 2023;384:102&#x2013;108. doi: 10.1124/jpet.122.001210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001210</ArticleId><ArticleId IdType="pubmed">35779946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., Santulli G. What Is Linking COVID-19 and Endothelial Dysfunction? Updates on Nanomedicine and Bioengineering from the 2020 AHA Scientific Sessions. Eur. Hear. J.-Cardiovasc. Pharmacother. 2021;7:e2&#x2013;e3. doi: 10.1093/ehjcvp/pvaa145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvaa145</ArticleId><ArticleId IdType="pmc">PMC7799225</ArticleId><ArticleId IdType="pubmed">33377481</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad-Kazan M., Makki R., Skafi N., El Homsi M., Hamade A., El Majzoub R., Hamade E., Fayyad-Kazan H., Badran B. Circulating MiRNAs: Potential Diagnostic Role for Coronavirus Disease 2019 (COVID-19) Infect. Genet. Evol. 2021;94:105020. doi: 10.1016/j.meegid.2021.105020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105020</ArticleId><ArticleId IdType="pmc">PMC8325559</ArticleId><ArticleId IdType="pubmed">34343725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., Kansakar U., Sardu C., Messina V., Jankauskas S.S., Marfella R., Maggi P., Wang X., Mone P., Paolisso G., et al. Exosomal MiR-145 and MiR-885 Regulate Thrombosis in COVID-19. J. Pharmacol. Exp. Ther. 2023;384:109&#x2013;115. doi: 10.1124/jpet.122.001209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001209</ArticleId><ArticleId IdType="pmc">PMC9827505</ArticleId><ArticleId IdType="pubmed">35772782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The Pathogenesis and Treatment of the `Cytokine Storm&#x2019; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan K., Gupta M., Sarwat M. Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases. Front. Immunol. 2020;10:3081. doi: 10.3389/fimmu.2019.03081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03081</ArticleId><ArticleId IdType="pmc">PMC6992578</ArticleId><ArticleId IdType="pubmed">32038627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed H.A., Abdelkafy A.E., Khairy R.M.M., Abdelraheim S.R., Kamel B.A., Marey H. MicroRNAs and Cytokines as Potential Predictive Biomarkers for COVID-19 Disease Progression. Sci. Rep. 2023;13:3531. doi: 10.1038/s41598-023-30474-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-30474-6</ArticleId><ArticleId IdType="pmc">PMC9979137</ArticleId><ArticleId IdType="pubmed">36864077</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Yu H., Guo Q. MicroRNA-20a Promotes Inflammation via the Nuclear Factor-&#x3ba;B Signaling Pathway in Pediatric Pneumonia. Mol. Med. Rep. 2017;17:612&#x2013;617. doi: 10.3892/mmr.2017.7899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7899</ArticleId><ArticleId IdType="pubmed">29115456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevinsky G.A., Buneva V.N. Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and Bacterial Diseases. Sci. World J. 2010;10:1203&#x2013;1233. doi: 10.1100/tsw.2010.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1100/tsw.2010.98</ArticleId><ArticleId IdType="pmc">PMC5763945</ArticleId><ArticleId IdType="pubmed">20602079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolmacheva A.S., Onvumere M.K., Sedykh S.E., Timofeeva A.M., Nevinsky G.A. Catalase Activity of IgGs of Patients Infected with SARS-CoV-2. Int. J. Mol. Sci. 2023;24:10081. doi: 10.3390/ijms241210081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241210081</ArticleId><ArticleId IdType="pmc">PMC10298519</ArticleId><ArticleId IdType="pubmed">37373231</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell S.A., Sachithanandham J., Mudrak N.J., Zhu X., Farhang P.A., Cordero R.J.B., Wear M.P., Shapiro J.R., Park H.-S., Klein S.L., et al. Spike-Protein Proteolytic Antibodies in COVID-19 Convalescent Plasma Contribute to SARS-CoV-2 Neutralization. Cell Chem. Biol. 2023;30:726&#x2013;738.e4. doi: 10.1016/j.chembiol.2023.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2023.05.011</ArticleId><ArticleId IdType="pmc">PMC10288624</ArticleId><ArticleId IdType="pubmed">37354908</ArticleId></ArticleIdList></Reference><Reference><Citation>Timofeeva A.M., Shayakhmetova L.S., Nikitin A.O., Sedykh T.A., Matveev A.L., Shanshin D.V., Volosnikova E.A., Merkuleva I.A., Shcherbakov D.N., Tikunova N.V., et al. Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins. Biomedicines. 2024;12:1007. doi: 10.3390/biomedicines12051007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12051007</ArticleId><ArticleId IdType="pmc">PMC11118737</ArticleId><ArticleId IdType="pubmed">38790969</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G., Budhathoki S., Lee G.-Y., Oh K., Ham Y., Kim Y.-J., Lim Y., Hoang P., Lee Y., Lim S.-W., et al. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (ScFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Viruses. 2021;13:650. doi: 10.3390/v13040650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040650</ArticleId><ArticleId IdType="pmc">PMC8068894</ArticleId><ArticleId IdType="pubmed">33918914</ArticleId></ArticleIdList></Reference><Reference><Citation>Luong Q.X.T., Hoang P.T., Lee Y., Ayun R.Q., Na K., Park S., Lin C., Ho P.T., Lee T.-K., Lee S. An RNA-Hydrolyzing Recombinant Minibody Prevents Both Influenza A Virus and Coronavirus in Co-Infection Models. Sci. Rep. 2024;14:8472. doi: 10.1038/s41598-024-52810-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-52810-0</ArticleId><ArticleId IdType="pmc">PMC11009316</ArticleId><ArticleId IdType="pubmed">38605110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang P.T., Luong Q.X.T., Ayun R.Q., Lee Y., Oh K.-J., Kim T., Lee T.-K., Lee S. A Synergistic Therapy against Influenza Virus A/H1N1/PR8 by a HA1 Specific Neutralizing Single-Domain VL and an RNA Hydrolyzing ScFv. Front. Microbiol. 2024;15:1355599. doi: 10.3389/fmicb.2024.1355599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1355599</ArticleId><ArticleId IdType="pmc">PMC11066198</ArticleId><ArticleId IdType="pubmed">38706966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Hoang P., Kim D., Ayun R., Luong Q., Na K., Kim T., Oh Y., Kim W.-K., Lee S. A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs. Viruses. 2022;14:1105. doi: 10.3390/v14051105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051105</ArticleId><ArticleId IdType="pmc">PMC9146509</ArticleId><ArticleId IdType="pubmed">35632846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov E.A., Kabirova E.M., Sizikov A.E., Buneva V.N., Nevinsky G.A. IgGs-Abzymes from the Sera of Patients with Systemic Lupus Erythematosus Hydrolyzed MiRNAs. J. Inflamm. Res. 2020;13:681&#x2013;699. doi: 10.2147/JIR.S258558.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S258558</ArticleId><ArticleId IdType="pmc">PMC7550216</ArticleId><ArticleId IdType="pubmed">33116748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov E.A., Kabirova E.M., Buneva V.N., Nevinsky G.A. IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze MiRNAs. Int. J. Mol. Sci. 2021;22:2812. doi: 10.3390/ijms22062812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22062812</ArticleId><ArticleId IdType="pmc">PMC8000798</ArticleId><ArticleId IdType="pubmed">33802122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevinsky G.A., Urusov A.E., Aulova K.S., Ermakov E.A. Experimental Autoimmune Encephalomyelitis of Mice: IgGs from the Sera of Mice Hydrolyze MiRNAs. Int. J. Mol. Sci. 2023;24:4433. doi: 10.3390/ijms24054433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054433</ArticleId><ArticleId IdType="pmc">PMC10002156</ArticleId><ArticleId IdType="pubmed">36901861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov E.A., Ivanova S.A., Buneva V.N., Nevinsky G.A. Hydrolysis by Catalytic IgGs of MicroRNA Specific for Patients with Schizophrenia. IUBMB Life. 2018;70:153&#x2013;164. doi: 10.1002/iub.1712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1712</ArticleId><ArticleId IdType="pubmed">29341394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Ehm F., Vivirito A., Wende D., Batram M., Loser F., Menzer S., Jacob J., Roessler M., Seifert M., et al. Incident Autoimmune Diseases in Association with SARS-CoV-2 Infection: A Matched Cohort Study. Clin. Rheumatol. 2023;42:2905&#x2013;2914. doi: 10.1007/s10067-023-06670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06670-0</ArticleId><ArticleId IdType="pmc">PMC10497688</ArticleId><ArticleId IdType="pubmed">37335408</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-Dimensional Characterization of Post-Acute Sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-Month Neurological and Psychiatric Outcomes in 236 379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-Term Cardiovascular Outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Al-Aly Z. Risks of Mental Health Outcomes in People with COVID-19: Cohort Study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-Term Neurologic Outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Ehm F., et al. Post-COVID-19-Associated Morbidity in Children, Adolescents, and Adults: A Matched Cohort Study Including More than 157,000 Individuals with COVID-19 in Germany. PLOS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N., Rezaei N. Autoimmune Complications of COVID-19. J. Med. Virol. 2022;94:54&#x2013;62. doi: 10.1002/jmv.27292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27292</ArticleId><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Yen-Ting Chen T., Wang S.-I., Hung Y.-M., Chen H.-Y., Wei C.-C.J. Risk of Autoimmune Diseases in Patients with COVID-19: A Retrospective Cohort Study. eClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Klink G.V., Safina K.R., Garushyants S.K., Moldovan M., Nabieva E., Komissarov A.B., Lioznov D., Bazykin G.A. Spread of Endemic SARS-CoV-2 Lineages in Russia before April 2021. PLoS ONE. 2022;17:e0270717. doi: 10.1371/journal.pone.0270717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270717</ArticleId><ArticleId IdType="pmc">PMC9299347</ArticleId><ArticleId IdType="pubmed">35857745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Gao Y., Li Z., Miao Y., Huang Z., Liu X., Xie L., Li H., Wen W., Zheng Y., et al. The Noncoding and Coding Transcriptional Landscape of the Peripheral Immune Response in Patients with COVID-19. Clin. Transl. Med. 2020;10:e200. doi: 10.1002/ctm2.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell R.M., Rao D.S., Baltimore D. MicroRNA Regulation of Inflammatory Responses. Annu. Rev. Immunol. 2012;30:295&#x2013;312. doi: 10.1146/annurev-immunol-020711-075013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-075013</ArticleId><ArticleId IdType="pubmed">22224773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheedy F.J. Turning 21: Induction of MiR-21 as a Key Switch in the Inflammatory Response. Front. Immunol. 2015;6:19. doi: 10.3389/fimmu.2015.00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00019</ArticleId><ArticleId IdType="pmc">PMC4310327</ArticleId><ArticleId IdType="pubmed">25688245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H.S., Sivachandran N., Lau A., Boudreau E., Zhao J.L., Baltimore D., Delgado-Olguin P., Cybulsky M.I., Fish J.E. MicroRNA-146 Represses Endothelial Activation by Inhibiting Pro-inflammatory Pathways. EMBO Mol. Med. 2013;5:1017&#x2013;1034. doi: 10.1002/emmm.201202318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202318</ArticleId><ArticleId IdType="pmc">PMC3721471</ArticleId><ArticleId IdType="pubmed">23733368</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimenta R., Viana N.I., Dos Santos G.A., Candido P., Guimar&#xe3;es V.R., Rom&#xe3;o P., Silva I.A., de Camargo J.A., Hatanaka D.M., Queiroz P.G.S., et al. MiR-200c-3p Expression May Be Associated with Worsening of the Clinical Course of Patients with COVID-19. Mol. Biol. Res. Commun. 2021;10:141&#x2013;147. doi: 10.22099/mbrc.2021.40555.1631.</Citation><ArticleIdList><ArticleId IdType="doi">10.22099/mbrc.2021.40555.1631</ArticleId><ArticleId IdType="pmc">PMC8340313</ArticleId><ArticleId IdType="pubmed">34476267</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker O., El Amir M., Elfatah Y.A., Elwi H.M. Expression Patterns of LncRNA MALAT-1 in SARS-CoV-2 Infection and Its Potential Effect on Disease Severity via MiR-200c-3p and SIRT1. Biochem. Biophys. Rep. 2023;36:101562. doi: 10.1016/j.bbrep.2023.101562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2023.101562</ArticleId><ArticleId IdType="pmc">PMC10641570</ArticleId><ArticleId IdType="pubmed">37965063</ArticleId></ArticleIdList></Reference><Reference><Citation>Roustai Geraylow K., Hemmati R., Kadkhoda S., Ghafouri-Fard S. MiRNA Expression in COVID-19. Gene Rep. 2022;28:101641. doi: 10.1016/j.genrep.2022.101641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2022.101641</ArticleId><ArticleId IdType="pmc">PMC9288248</ArticleId><ArticleId IdType="pubmed">35875722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersisyan S., Shkurnikov M., Turchinovich A., Knyazev E., Tonevitsky A. Integrative Analysis of MiRNA and MRNA Sequencing Data Reveals Potential Regulatory Mechanisms of ACE2 and TMPRSS2. PLoS ONE. 2020;15:e0235987. doi: 10.1371/journal.pone.0235987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0235987</ArticleId><ArticleId IdType="pmc">PMC7390267</ArticleId><ArticleId IdType="pubmed">32726325</ArticleId></ArticleIdList></Reference><Reference><Citation>Onabajo O.O., Banday A.R., Stanifer M.L., Yan W., Obajemu A., Santer D.M., Florez-Vargas O., Piontkivska H., Vargas J.M., Ring T.J., et al. Interferons and Viruses Induce a Novel Truncated ACE2 Isoform and Not the Full-Length SARS-CoV-2 Receptor. Nat. Genet. 2020;52:1283&#x2013;1293. doi: 10.1038/s41588-020-00731-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00731-9</ArticleId><ArticleId IdType="pmc">PMC9377523</ArticleId><ArticleId IdType="pubmed">33077916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensi S., Goebel A. Human Auto-IgG Purification from High Volume Serum Sample by Protein G Affinity Purification. Bio-Protocol. 2022;12:e4562. doi: 10.21769/BioProtoc.4562.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.4562</ArticleId><ArticleId IdType="pmc">PMC9729856</ArticleId><ArticleId IdType="pubmed">36561118</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S., Li L., Kalaga R., Wilkins-Stevens P., Stevens F.J., Solomon A. Natural Catalytic Antibodies: Peptide-Hydrolyzing Activities of Bence Jones Proteins and VL Fragment. J. Biol. Chem. 1995;270:15257&#x2013;15261. doi: 10.1074/jbc.270.25.15257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.25.15257</ArticleId><ArticleId IdType="pubmed">7797511</ArticleId></ArticleIdList></Reference><Reference><Citation>Roush S., Slack F.J. The Let-7 Family of MicroRNAs. Trends Cell Biol. 2008;18:505&#x2013;516. doi: 10.1016/j.tcb.2008.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2008.07.007</ArticleId><ArticleId IdType="pubmed">18774294</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Chiang V.L. Facile Means for Quantifying Microrna Expression by Real-Time PCR. Biotechniques. 2005;39:519&#x2013;525. doi: 10.2144/000112010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000112010</ArticleId><ArticleId IdType="pubmed">16235564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Real-Time Quantification of MicroRNAs by Stem-Loop RT-PCR. Nucleic Acids Res. 2005;33:e179. doi: 10.1093/nar/gni178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gni178</ArticleId><ArticleId IdType="pmc">PMC1292995</ArticleId><ArticleId IdType="pubmed">16314309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Q., Li X., Meng Y., Wu Z., Guo M., Zhao Y., Fu X., Han W. A Facile and Specific Assay for Quantifying MicroRNA by an Optimized RT-QPCR Approach. PLoS ONE. 2012;7:e46890. doi: 10.1371/journal.pone.0046890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046890</ArticleId><ArticleId IdType="pmc">PMC3465266</ArticleId><ArticleId IdType="pubmed">23071657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov E.A., Nevinsky G.A., Buneva V.N. Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States. Int. J. Mol. Sci. 2020;21:5392. doi: 10.3390/ijms21155392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155392</ArticleId><ArticleId IdType="pmc">PMC7432551</ArticleId><ArticleId IdType="pubmed">32751323</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos G.L., Reczko M., Simossis V.A., Sethupathy P., Hatzigeorgiou A.G. The Database of Experimentally Supported Targets: A Functional Update of TarBase. Nucleic Acids Res. 2009;37:D155&#x2013;D158. doi: 10.1093/nar/gkn809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn809</ArticleId><ArticleId IdType="pmc">PMC2686456</ArticleId><ArticleId IdType="pubmed">18957447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis B.P., Burge C.B., Bartel D.P. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates That Thousands of Human Genes Are MicroRNA Targets. Cell. 2005;120:15&#x2013;20. doi: 10.1016/j.cell.2004.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.035</ArticleId><ArticleId IdType="pubmed">15652477</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A., Balc&#x131; H., Hanspers K., Coort S.L., Martens M., Slenter D.N., Ehrhart F., Digles D., Waagmeester A., Wassink I., et al. WikiPathways 2024: Next Generation Pathway Database. Nucleic Acids Res. 2024;52:D679&#x2013;D689. doi: 10.1093/nar/gkad960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad960</ArticleId><ArticleId IdType="pmc">PMC10767877</ArticleId><ArticleId IdType="pubmed">37941138</ArticleId></ArticleIdList></Reference><Reference><Citation>Pico A.R., Kelder T., van Iersel M.P., Hanspers K., Conklin B.R., Evelo C. WikiPathways: Pathway Editing for the People. PLoS Biol. 2008;6:e184. doi: 10.1371/journal.pbio.0060184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060184</ArticleId><ArticleId IdType="pmc">PMC2475545</ArticleId><ArticleId IdType="pubmed">18651794</ArticleId></ArticleIdList></Reference><Reference><Citation>Buggele W.A., Johnson K.E., Horvath C.M. Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression. J. Biol. Chem. 2012;287:31027&#x2013;31040. doi: 10.1074/jbc.M112.387670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.387670</ArticleId><ArticleId IdType="pmc">PMC3438935</ArticleId><ArticleId IdType="pubmed">22822053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelis D.d.F., Freitas D.F.d., Machado A.S., Crespo T.S., Santos S.H.S. Angiotensin-(1-7), Adipokines and Inflammation. Metabolism. 2019;95:36&#x2013;45. doi: 10.1016/j.metabol.2019.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2019.03.006</ArticleId><ArticleId IdType="pubmed">30905634</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Yu C.-H., Li W., Li T., Luo W., Huang S., Wu P.-S., Cai S.-X., Li X. Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-&#x39a;B Pathway. Am. J. Respir. Cell Mol. Biol. 2014;50:723&#x2013;736. doi: 10.1165/rcmb.2012-0451OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2012-0451OC</ArticleId><ArticleId IdType="pubmed">24168260</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalan R., Bornstein S.R., El-Armouche A., Rodionov R.N., Markov A., Wielockx B., Beuschlein F., Boehm B.O. The ACE-2 in COVID-19: Foe or Friend? Horm. Metab. Res. 2020;52:257&#x2013;263. doi: 10.1055/a-1155-0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1155-0501</ArticleId><ArticleId IdType="pmc">PMC7339082</ArticleId><ArticleId IdType="pubmed">32340044</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhal B.D., Dang M., Dang V., Llatos R., Cano E., Abdul-Hafez A., Markey J., Piasecki C.C., Molina-Molina M. Cell Cycle Dependence of ACE-2 Explains Downregulation in Idiopathic Pulmonary Fibrosis. Eur. Respir. J. 2013;42:198&#x2013;210. doi: 10.1183/09031936.00015612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00015612</ArticleId><ArticleId IdType="pubmed">23100504</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P., Cavallini C., Spanevello A., Angeli F. The Pivotal Link between ACE2 Deficiency and SARS-CoV-2 Infection. Eur. J. Intern. Med. 2020;76:14&#x2013;20. doi: 10.1016/j.ejim.2020.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.04.037</ArticleId><ArticleId IdType="pmc">PMC7167588</ArticleId><ArticleId IdType="pubmed">32336612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth Z., Kiss E., Takacs I. The Role of Epigenetic Regulator SIRT1 in Balancing the Homeostasis and Preventing the Formation of Specific &#x201c;Soil&#x201d; of Metabolic Disorders and Related Cancers. Front. Biosci. 2022;27:253. doi: 10.31083/j.fbl2709253.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2709253</ArticleId><ArticleId IdType="pubmed">36224002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi G.A., Sacco O., Capizzi A., Mastromarino P. Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? Front. Immunol. 2021;12:670955. doi: 10.3389/fimmu.2021.670955.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.670955</ArticleId><ArticleId IdType="pmc">PMC8172170</ArticleId><ArticleId IdType="pubmed">34093569</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., et al. Angiotensin-converting Enzyme 2 (ACE2), SARS-CoV-2 and the Pathophysiology of Coronavirus Disease 2019 (COVID-19) J. Pathol. 2020;251:228&#x2013;248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Varambally S., Maher C.A., Cao Q., Chockley P., Toubai T., Malter C., Nieves E., Tawara I., Wang Y., et al. Targeting of MicroRNA-142-3p in Dendritic Cells Regulates Endotoxin-Induced Mortality. Blood. 2011;117:6172&#x2013;6183. doi: 10.1182/blood-2010-12-325647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-12-325647</ArticleId><ArticleId IdType="pmc">PMC3122940</ArticleId><ArticleId IdType="pubmed">21474672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., Manjunath N. MiRNA Profiling of Na&#xef;ve, Effector and Memory CD8 T Cells. PLoS ONE. 2007;2:e1020. doi: 10.1371/journal.pone.0001020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001020</ArticleId><ArticleId IdType="pmc">PMC2000354</ArticleId><ArticleId IdType="pubmed">17925868</ArticleId></ArticleIdList></Reference><Reference><Citation>Junker A., Krumbholz M., Eisele S., Mohan H., Augstein F., Bittner R., Lassmann H., Wekerle H., Hohlfeld R., Meinl E. MicroRNA Profiling of Multiple Sclerosis Lesions Identifies Modulators of the Regulatory Protein CD47. Brain. 2009;132:3342&#x2013;3352. doi: 10.1093/brain/awp300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp300</ArticleId><ArticleId IdType="pubmed">19952055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Zhou J., Zhong Y., Jiang L., Mu P., Li Y., Singh N., Nagarkatti M., Nagarkatti P. Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis. Int. J. Med. Sci. 2014;11:810&#x2013;818. doi: 10.7150/ijms.8647.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.8647</ArticleId><ArticleId IdType="pmc">PMC4057480</ArticleId><ArticleId IdType="pubmed">24936144</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandolesi G., De Vito F., Musella A., Gentile A., Bullitta S., Fresegna D., Sepman H., Di Sanza C., Haji N., Mori F., et al. MiR-142-3p Is a Key Regulator of IL-1&#x3b2;-Dependent Synaptopathy in Neuroinflammation. J. Neurosci. 2017;37:546&#x2013;561. doi: 10.1523/JNEUROSCI.0851-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0851-16.2016</ArticleId><ArticleId IdType="pmc">PMC6596761</ArticleId><ArticleId IdType="pubmed">28100738</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito F., Musella A., Fresegna D., Rizzo F.R., Gentile A., Stampanoni Bassi M., Gilio L., Buttari F., Procaccini C., Colamatteo A., et al. MiR-142-3p Regulates Synaptopathy-driven Disease Progression in Multiple Sclerosis. Neuropathol. Appl. Neurobiol. 2022;48:e12765. doi: 10.1111/nan.12765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12765</ArticleId><ArticleId IdType="pmc">PMC9291627</ArticleId><ArticleId IdType="pubmed">34490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.Y.C., Hoiland R.L., Stukas S., Wellington C.L., Sekhon M.S. Confronting the Controversy: Interleukin-6 and the COVID-19 Cytokine Storm Syndrome. Eur. Respir. J. 2020;56:2003006. doi: 10.1183/13993003.03006-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03006-2020</ArticleId><ArticleId IdType="pmc">PMC7474149</ArticleId><ArticleId IdType="pubmed">32883678</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Li G. Immune Response and Blood&#x2013;Brain Barrier Dysfunction during Viral Neuroinvasion. Innate Immun. 2021;27:109&#x2013;117. doi: 10.1177/1753425920954281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425920954281</ArticleId><ArticleId IdType="pmc">PMC7882805</ArticleId><ArticleId IdType="pubmed">32903111</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Xu L., Liang X., Liu X., Zhao Y., Ma C., Gao L. Tim-4 in Health and Disease: Friend or Foe? Front. Immunol. 2020;11:537. doi: 10.3389/fimmu.2020.00537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00537</ArticleId><ArticleId IdType="pmc">PMC7142236</ArticleId><ArticleId IdType="pubmed">32300343</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago C., Ballesteros A., Mart&#xed;nez-Mu&#xf1;oz L., Mellado M., Kaplan G.G., Freeman G.J., Casasnovas J.M. Structures of T Cell Immunoglobulin Mucin Protein 4 Show a Metal-Ion-Dependent Ligand Binding Site Where Phosphatidylserine Binds. Immunity. 2007;27:941&#x2013;951. doi: 10.1016/j.immuni.2007.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.11.008</ArticleId><ArticleId IdType="pmc">PMC2330274</ArticleId><ArticleId IdType="pubmed">18083575</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Benigni A., Casiraghi F., Ng L.F.P., Renia L., Remuzzi G. Immunity, Endothelial Injury and Complement-Induced Coagulopathy in COVID-19. Nat. Rev. Nephrol. 2021;17:46&#x2013;64. doi: 10.1038/s41581-020-00357-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00357-4</ArticleId><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson D., Raju S., Wu R., Ching C., Veitch S., Rathnakumar K., Boudreau E., Howe K.L., Fish J.E. Overcoming Barriers. Arterioscler. Thromb. Vasc. Biol. 2020;40:1818&#x2013;1829. doi: 10.1161/ATVBAHA.120.314558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314558</ArticleId><ArticleId IdType="pmc">PMC7370857</ArticleId><ArticleId IdType="pubmed">32510978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Tanaka T., Inoue H., Ono C., Hashimoto S., Kioi Y., Matsumoto H., Matsuura H., Matsubara T., Shimizu K., et al. IL-6 Trans-Signaling Induces Plasminogen Activator Inhibitor-1 from Vascular Endothelial Cells in Cytokine Release Syndrome. Proc. Natl. Acad. Sci. USA. 2020;117:22351&#x2013;22356. doi: 10.1073/pnas.2010229117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010229117</ArticleId><ArticleId IdType="pmc">PMC7486751</ArticleId><ArticleId IdType="pubmed">32826331</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism Risk of COVID-19 Is High and Associated with a Higher Risk of Mortality: A Systematic Review and Meta-Analysis. eClinicalMedicine. 2020;29&#x2013;30:100639. doi: 10.1016/j.eclinm.2020.100639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100639</ArticleId><ArticleId IdType="pmc">PMC7679115</ArticleId><ArticleId IdType="pubmed">33251499</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G., Morrow D.A. Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA. 2020;324:2548. doi: 10.1001/jama.2020.23422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23422</ArticleId><ArticleId IdType="pubmed">33226423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S., Quintili A.L., Karamchandani K., Bose S. Thromboembolic Disease in COVID-19 Patients: A Brief Narrative Review. J. Intensive Care. 2020;8:70. doi: 10.1186/s40560-020-00483-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00483-y</ArticleId><ArticleId IdType="pmc">PMC7487447</ArticleId><ArticleId IdType="pubmed">32939266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health System. JAMA. 2020;324:799. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Feng X., Zhang D., Jiang C., Mei H., Wang J., Zhang C., Li H., Xia X., Kong S., et al. Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China. Circulation. 2020;142:114&#x2013;128. doi: 10.1161/CIRCULATIONAHA.120.046702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.046702</ArticleId><ArticleId IdType="pubmed">32421381</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjorgjieva M., Sobolewski C., Dolicka D., Correia de Sousa M., Foti M. MiRNAs and NAFLD: From Pathophysiology to Therapy. Gut. 2019;68:2065&#x2013;2079. doi: 10.1136/gutjnl-2018-318146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-318146</ArticleId><ArticleId IdType="pubmed">31300518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca N., Pezzullo M., De Leo I., Truda A., Marchese G., Russo A., Potenza N. A Novel CeRNET Relying on the LncRNA JPX, MiR-378a-3p, and Its MRNA Targets in Lung Cancer. Cancers. 2024;16:1526. doi: 10.3390/cancers16081526.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16081526</ArticleId><ArticleId IdType="pmc">PMC11049386</ArticleId><ArticleId IdType="pubmed">38672608</ArticleId></ArticleIdList></Reference><Reference><Citation>Moatar A.I., Chis A.R., Marian C., Sirbu I.-O. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. Int. J. Mol. Sci. 2022;23:9239. doi: 10.3390/ijms23169239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169239</ArticleId><ArticleId IdType="pmc">PMC9409149</ArticleId><ArticleId IdType="pubmed">36012503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury D., Nayeem M., Vanderven H.A., Sarker S. Role of MiRNA in Highly Pathogenic H5 Avian Influenza Virus Infection: An Emphasis on Cellular and Chicken Models. Viruses. 2024;16:1102. doi: 10.3390/v16071102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16071102</ArticleId><ArticleId IdType="pmc">PMC11281567</ArticleId><ArticleId IdType="pubmed">39066264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. MicroRNAs. Cell. 2004;116:281&#x2013;297. doi: 10.1016/S0092-8674(04)00045-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(04)00045-5</ArticleId><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Timofeeva A.M., Sedykh S.E., Sedykh T.A., Nevinsky G.A. Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2. Vaccines. 2023;11:1494. doi: 10.3390/vaccines11091494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11091494</ArticleId><ArticleId IdType="pmc">PMC10535122</ArticleId><ArticleId IdType="pubmed">37766170</ArticleId></ArticleIdList></Reference><Reference><Citation>Timofeeva A.M., Sedykh S.E., Ermakov E.A., Matveev A.L., Odegova E.I., Sedykh T.A., Shcherbakov D.N., Merkuleva I.A., Volosnikova E.A., Nesmeyanova V.S., et al. Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune. Int. J. Mol. Sci. 2022;23:13681. doi: 10.3390/ijms232213681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213681</ArticleId><ArticleId IdType="pmc">PMC9693483</ArticleId><ArticleId IdType="pubmed">36430159</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen P., Gommers R., Oliphant T.E., Haberland M., Reddy T., Cournapeau D., Burovski E., Peterson P., Weckesser W., Bright J., et al. SciPy 1.0: Fundamental Algorithms for Scientific Computing in Python. Nat. Methods. 2020;17:261&#x2013;272. doi: 10.1038/s41592-019-0686-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0686-2</ArticleId><ArticleId IdType="pmc">PMC7056644</ArticleId><ArticleId IdType="pubmed">32015543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutmon M., Ehrhart F., Willighagen E.L., Evelo C.T., Coort S.L. CyTargetLinker App Update: A Flexible Solution for Network Extension in Cytoscape. F1000Research. 2018;7:743. doi: 10.12688/f1000research.14613.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.14613.1</ArticleId><ArticleId IdType="pmc">PMC6707396</ArticleId><ArticleId IdType="pubmed">31489175</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>